Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Learn more about HealthTree
How Targeting Inflammation May Hold the Key to MPN Well-Being with Dr. Angela Fleischman image

How Targeting Inflammation May Hold the Key to MPN Well-Being with Dr. Angela Fleischman

Can't make it to the event?
We send a recording to all registered participants of the event!
Oct 06, 2026
05:00PM - 06:00PM EDT
Online Event
Overview

Join the HealthTree Foundation for an MPN-focused webinar featuring MPN specialist Dr. Angela Fleischman from the University of California, Irvine. Dr. Fleischman will share current research on the key role chronic inflammation plays as a core driver of MPNs. You’ll learn how her work aims to deepen our understanding of inflammation and highlight potential ways to combat it. Join us live to ask your questions directly to an expert, or register to receive the recording afterward!

Agenda
5:00 PM
Introductions
Dalton Bean

Dalton introduces the agenda of the event and featured speaker Dr. Angela Fleischman

5:05 PM
Presentation
Angela Fleischman, MD PhD

Dr. Fleischman talks about targetting inflammation

5:35 PM
Questions & Answers
Audience

Bring your questions!

Speakers & Moderators
Healthtree contact Dalton Bean

Dalton Bean

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Healthtree contact Angela Fleischman, MD PhD

Angela Fleischman, MD PhD

Dr. Angela Fleischman is a UCI Health physician-scientist investigating hematologic malignancies. She integrates her research with the clinical care of patients with these blood disorders. Fleischman earned her medical degree and a PhD in cancer biology from Stanford University in Palo Alto, Calif. Next she completed an internal medicine and a medical oncology fellowship at Oregon Health & Science University in Portland.   Fleischman's longstanding interest in blood cell development began during her PhD studies at Stanford. She joined the UCI Health Chao Family Comprehensive Cancer Center as an assistant professor in 2013 and began developing an independent laboratory group focusing on the pathogenesis of myeloproliferative neoplasm (MPN), a chronic leukemia. Her research interests also include a hematologic malignancies and hematopoietic stem cells. Her overarching research goal is to identify what drives disease initiation in MPN and, ultimately, to translate her scientific discoveries into therapies that benefit MPN patients.